Autumn, I am also a long term holder on this. I wonder who initiated the termination? It says Inovio Pharmaceuticals (INO) announced the company and Roche have terminated their 2013 collaboration, option, and license agreement to co-develop INO-5150
Did Dr Kim see a way out of sharing the rights? Why would Roche want to terminate? Phase 1 didn't even start...